{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:20:40Z","timestamp":1788618040071,"version":"build-2803163510"},"reference-count":46,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2003,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Lipopolysaccharide (LPS) preparations are known to often contain substances which activate cells through Toll-like receptor 2 (TLR2), and it is suspected that bacterial lipoproteins are responsible for this activation. We compared the mode of action of the TLR2-stimulatory substances with that of a synthetic bacterial lipopeptide (tripalmitoyl-Cys-Ser-Ser-Asn-Ala [Pam<jats:sub>3<\/jats:sub>CSSNA]), as well as with that of peptidoglycan. Six out of eight LPS preparations tested induced NF-\u03baB-dependent reporter activity in 293 cells expressing CD14 and TLR2. Phenol extract (PEX) prepared from<jats:italic>Escherichia coli<\/jats:italic>LPS by modified phenol extraction induced reporter activity in 293 cells expressing TLR2, and this activity was enhanced by coexpression of CD14, whereas the activity of Pam<jats:sub>3<\/jats:sub>CSSNA was not dependent on CD14. The activity of PEX, but not that of Pam<jats:sub>3<\/jats:sub>CSSNA or peptidoglycan, was also enhanced by LPS binding protein or serum and blocked by polymyxin B. In addition, the activity of PEX was inhibited by a lipid A precursor (compound 406) in 293 cells expressing CD14 and TLR2. These results indicate that<jats:italic>E. coli<\/jats:italic>LPS preparations contain LPS-mimetic TLR2-stimulatory substances which differ from bacterial lipopeptides or peptidoglycan.<\/jats:p>","DOI":"10.1128\/iai.71.6.3221-3226.2003","type":"journal-article","created":{"date-parts":[[2003,5,21]],"date-time":"2003-05-21T23:33:12Z","timestamp":1053559992000},"page":"3221-3226","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["Lipopolysaccharide-Mimetic Activities of a Toll-Like Receptor 2-Stimulatory Substance(s) in Enterobacterial Lipopolysaccharide Preparations"],"prefix":"10.1128","volume":"71","author":[{"given":"Masashi","family":"Muroi","sequence":"first","affiliation":[{"name":"Division of Microbiology, National Institute of Health Sciences, Setagaya, Tokyo 158-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Division of Microbiology, National Institute of Health Sciences, Setagaya, Tokyo 158-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Azumi-Mayuzumi","sequence":"additional","affiliation":[{"name":"Division of Microbiology, National Institute of Health Sciences, Setagaya, Tokyo 158-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Tanamoto","sequence":"additional","affiliation":[{"name":"Division of Microbiology, National Institute of Health Sciences, Setagaya, Tokyo 158-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.10.4173-4181.1993"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5428.736"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(99)00046-1"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.16.10689"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.6.1906-1912.1996"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.20.9288"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.6.2964-2968.1999"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1969.tb00601.x"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.1.269"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(99)00050-3"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.4049\/jimmunol.162.12.6971","volume":"162","year":"1999","unstructured":"Heine, H., C. J. Kirschning, E. Lien, B. G. Monks, M. Rothe, and D. T. Golenbock. 1999. Cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin. J. Immunol.162:6971-6975.","journal-title":"J. Immunol."},{"key":"e_1_3_2_13_2","first-page":"2382","volume":"163","year":"1999","unstructured":"Hirschfeld, M., C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Wooten, and J. J. Weis. 1999. Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol.163:2382-2386.","journal-title":"Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol."},{"key":"e_1_3_2_14_2","first-page":"618","volume":"165","year":"2000","unstructured":"Hirschfeld, M., Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis. 2000. Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol.165:618-622.","journal-title":"Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1477-1482.2001"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","volume":"162","year":"1999","unstructured":"Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol.162:3749-3752.","journal-title":"J. Immunol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.4.1736-1742.1999"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.11.2091"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.8.4012"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8541"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.47.33419"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.4049\/jimmunol.163.12.6748","volume":"163","year":"1999","unstructured":"Means, T. K., E. Lien, A. Yoshimura, S. Wang, D. T. Golenbock, and M. J. Fenton. 1999. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol.163:6748-6755.","journal-title":"J. Immunol."},{"key":"e_1_3_2_23_2","first-page":"3546","volume":"70","year":"2002","unstructured":"Muroi, M., T. Ohnishi, and K. Tanamoto. 2002. MD-2, a novel accessory molecule, is involved in species-specific actions of Salmonella lipid A. Infect. Immun.70:3546-3550.","journal-title":"MD-2, a novel accessory molecule, is involved in species-specific actions of Salmonella lipid A. Infect. Immun."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205966200"},{"key":"e_1_3_2_25_2","first-page":"6043","volume":"70","year":"2002","unstructured":"Muroi, M., and K. Tanamoto. 2002. The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide-induced activation of NF-\u03baB through human Toll-like receptor 4. Infect. Immun.70:6043-6047.","journal-title":"The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide-induced activation of NF-\u03baB through human Toll-like receptor 4. Infect. Immun."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.4.2610"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.6.3354"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010481200"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5396.2085"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.040565397"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.4.615"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.4049\/jimmunol.157.6.2549","volume":"157","year":"1996","unstructured":"Savedra, R., R. L. Delude, R. R. Ingalls, M. J. Fenton, and D. T. Golenbock. 1996. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. J. Immunol.157:2549-2554.","journal-title":"J. Immunol."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02529735"},{"key":"e_1_3_2_34_2","first-page":"17406","volume":"274","year":"1999","unstructured":"Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem.274:17406-17409.","journal-title":"Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem."},{"key":"e_1_3_2_35_2","first-page":"1777","volume":"189","year":"1999","unstructured":"Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med.189:1777-1782.","journal-title":"MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80119-3"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.2.554"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.6.3149"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.4049\/jimmunol.158.9.4430","volume":"158","year":"1997","unstructured":"Tanamoto, K., S. Azumi, Y. Haishima, H. Kumada, and T. Umemoto. 1997. The lipid A moiety of Porphyromonas gingivalis lipopolysaccharide specifically mediates the activation of C3H\/HeJ mice. J. Immunol.158:4430-4436.","journal-title":"J. Immunol."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.10.5780"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02233-0"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.13.040195.002253"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.4049\/jimmunol.162.10.5666","volume":"162","year":"1999","unstructured":"Vogel, S. N., D. Johnson, P. Y. Perera, A. Medvedev, L. Larivire, S. T. Qureshi, and D. Malo. 1999. Functional characterization of the effect of the C3H\/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation. J. Immunol.162:5666-5670.","journal-title":"J. Immunol."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/86354"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1698311"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/26239"},{"key":"e_1_3_2_47_2","first-page":"1","volume":"163","year":"1999","unstructured":"Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol.163:1-5.","journal-title":"Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol."}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.71.6.3221-3226.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.71.6.3221-3226.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T09:10:20Z","timestamp":1682500220000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.71.6.3221-3226.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["10.1128\/IAI.71.6.3221-3226.2003"],"URL":"https:\/\/doi.org\/10.1128\/iai.71.6.3221-3226.2003","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]},"assertion":[{"value":"2002-11-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-03-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}